Venture capital fund · 1 deal
London
Every published round Plural took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Everlab | Series A | 4 Aug 2026 | $65m | Participant | datapile.co, Capital Brief, everlab.com.au, Cut Through Venture, medtechdaily.org, Startup Daily, Forbes Australia, SmartCompany, Dealroom, AirTree Ventures portfolio |
Companies Plural has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Everlab | 4 Aug 2026, Series A | 1 | 0 |
Fund closes reported for Plural, as distinct from the investments it has made.
Companies Plural has backed that another company then bought. An exit for the holding, not a deal Plural did.
Stories naming Plural. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne preventative healthcare startup Everlab raised a $65 million Series A led by Airtree Ventures to expand into the UK, with backing from cricketer Pat Cummins.
Melbourne preventive-health startup Everlab has banked an A$65 million Series A led by Airtree Ventures with Plural, Left Lane Capital and b2venture taking part, funding overseas growth starting in the UK.
Melbourne preventative health startup Everlab raised a $65 million Series A to fund UK expansion, with Airtree Ventures, Plural, b2venture, Left Lane Capital and cricketer Pat Cummins among the backers.
The preventative healthcare startup behind a diagnostics-and-data platform has banked a $65 million Series A, headed by Airtree Ventures with several funds and cricketer Pat Cummins taking part, to fund international growth.
Also Startup Daily·Forbes Australia·Dealroom·Cut Through Venture·Capital Brief·medtechdaily.org·everlab.com.au·datapile.co